Marius Wernig, MD, PhD
Associate Professor at Stanford University
MD, Technical University of Munich
PhD, Technical University of Munich
Postdoctoral Training, Whitehead Institute for Biomedical Research at MIT
Dr. Wernig is a member of the faculty of the Institute for Stem Cell Biology and Regenerative Medicine and the Department of Pathology at Stanford University. As a postdoctoral researcher at the Whitehead Institute, MIT, Dr. Wernig spearheaded one of the few research groups worldwide to successfully create pluripotent stem cells from mouse skin cells.
Dr. Wernig’s research focuses on reprogramming skin cells into functional neurons, and he and colleagues are currently conducting clinical trials to find treatments for recessive dystrophic epidermolysis bullosa (RDEB), a rare tissue disorder.
- NYSCF Innovator Improves Neuron Derivation from Stem Cells
- NYSCF Innovator Describes Potential Cell Replacement Strategy for Parkinson's Disease
- NYSCF Innovator Shows Nerve Cells Resist Transforming Into Other Cell Types
- Six NYSCF Innovators Named 2016 Faculty Scholars
- NYSCF Innovator Dissects Stem Cell-to-Neuron Reprogramming
- NYSCF - Robertson Investigator Identifies iPS Cell Reprogramming Regulators
- NYSCF - Robertson Prize Winner Lays Foundation for Blistering Skin Disorder Cure
- Dr. Marius Wernig Awarded 4th Annual NYSCF - Robertson Stem Cell Prize